Essential gene identification and drug target prioritization in Leishmania species (Q39343644)

11 September 2017

title

Essential gene identification and drug target prioritization in Leishmania species (English)

1 reference

11 September 2017

1 reference

M L Stanly Paul

1 reference

11 September 2017

Amandeep Kaur

series ordinal

1 reference

11 September 2017

Ankit Geete

series ordinal

1 reference

11 September 2017

M Elizabeth Sobhia

series ordinal

1 reference

11 September 2017

publication date

1 May 2014

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

1184-1195

1 reference

Functional genomics: identifying drug targets for parasitic diseases

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Monitoring drug resistance in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Drug resistance in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Drug resistance in Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Surprising variety in energy metabolism within Trypanosomatidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Estimating coarse gene network structure from large-scale gene perturbation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Reverse engineering the genotype-phenotype map with natural genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Reverse engineering gene networks: Integrating genetic perturbations with dynamical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Analysis of optimality in natural and perturbed metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Regulatory on/off minimization of metabolic flux changes after genetic perturbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Expression dynamics of a cellular metabolic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Properties of metabolic networks: structure versus function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Network biology: understanding the cell's functional organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Lethality and centrality in protein networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

A robustness-based approach to systems-oriented drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Drug discovery and development for neglected parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Structure-based systems biology for analyzing off-target binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Impact of stoichiometry representation on simulation of genotype-phenotype relationships in metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Large-scale 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Plasticity of genetic interactions in metabolic networks of yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Defining genetic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Synthetic enhancement in gene interaction: a genetic tool come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Epistatic interaction maps relative to multiple metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Three-dimensional structure of nucleoside diphosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Adenosine 5'-diphosphate binding and the active site of nucleoside diphosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: stability, oligomerization and structural determinants of nucleotide binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Review of "Leishmania- after the Genome" by Peter J. Myler and Nicolas Fasel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Fat synthesis in adipose tissue. An examination of stoichiometric constraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Advances in flux balance analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Combining global and local measures for structure-based druggability predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Identification of genome-scale metabolic network models using experimentally measured flux profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Analogous inhibitors of elastase do not always bind analogously

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

From Annotated Genomes to Metabolic Flux Models and Kinetic Parameter Fitting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Leishmaniasis: current status of available drugs and new potential drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Leishmania donovani trypanothione reductase: role of urea and guanidine hydrochloride in modulation of functional and structural properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Molecular basis of antimony treatment in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Polyamine metabolism in Leishmania: from arginine to trypanothione

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB70440H

21 January 2018

Identifiers

DOI

10.1039/C3MB70440H

1 reference

11 September 2017

1 reference